Pharmacoepidemiology of tacrine in Alzheimer's disease.
Begaud
B
B
Department of Clinical Pharmacology, CHU, Bordeaux, France.
Haramburu
F
F
Miremont
G
G
D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D017891:Pharmacoepidemiology / Q000458:organization & administration; D013619:Tacrine / Q000009:adverse effects / Q000627:therapeutic use*
D002800:Cholinesterase Inhibitors; D013619:Tacrine